The Alzheimer's Accountability and Investment Act (Public Law 118-93), enacted on October 1, 2024, mandates that the National ...

The finding has implications for all of us, write Harvard physician-researchers Christopher Worsham and Anupam Jena.

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according ...

Intra-Cellular’s promising clinical-stage pipeline includes treatments for a wide range of neurological indications.

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

Biogen (BIIB) and Eisai's (ESALF) (ESAIY) announce that U.S. FDA agreed to review their subcutaneous form of Alzheimer's ...

Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative ...

There is growing evidence that staying current with your vaccines can help prevent Alzheimer’s and other dementias. Studies ...

Alpha Cognition Expands Commercial and Medical Teams with Key Leadership Hires to Support the Launch of ZUNVEYL ...

A new study finds that dementia cases are expected to double to 1 million by 2060, with African-American cases potentially ...

Poorer cardiovascular health in childhood and adolescence may be linked to early differences in brain structure, particularly ...

A Potential Game-Changer for Mental Health TreatmentsSetting New Benchmarks: 65% Response Rate Shown in Completed Depression ...